Business · 31/01/2019Updated: 10/17/2026 · 1 min read
FDA Announces Draft Guidance for Industry on Marketing Status Notifications Under FD&C Act
Summary
The FDA is releasing a draft guidance to help companies submitting marketing status notifications for new and abbreviated drug applications comply with the Federal Food, Drug, and Cosmetic Act.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →